Scribd
Upload
5 views1 page

Annual Diabetes Medicine Launch in India

A new Indian pharmaceutical startup has developed a unique diabetes medicine that requires annual administration and is priced at ₹7000. The product faces challenges entering a competitive market dominated by affordable daily treatments and strong doctor influence. The objective is to generate short-term revenue through a successful product launch, assuming no regulatory restrictions exist.

Uploaded by

Faisal Ahmad
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
5 views1 page

Annual Diabetes Medicine Launch in India

A new Indian pharmaceutical startup has developed a unique diabetes medicine that requires annual administration and is priced at ₹7000. The product faces challenges entering a competitive market dominated by affordable daily treatments and strong doctor influence. The objective is to generate short-term revenue through a successful product launch, assuming no regulatory restrictions exist.

Uploaded by

Faisal Ahmad
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Market Entry Problem Statement

Overview
A group of researchers has launched an Indian pharmaceutical
startup and developed a unique diabetes medicine that needs to
be taken just once a year. Priced at ₹7000, this product offers a
major shift from traditional diabetes treatments that are taken
daily and cost less on a monthly basis.

While the product is clinically effective and ready for the market,
it enters a space that is highly cost-sensitive and dominated by
well-established treatment routines. The Indian diabetes care
market is competitive, with strong reliance on affordable daily
medication and significant influence from doctors in treatment
decisions.

Objective
To generate revenue in the short term by successfully launching
the product and driving initial sales.

Assumption
There are no regulatory restrictions from the government
on launching or selling the product.

You might also like